Eastwood Bio-Medical Canada Inc (EBM) Income Statement & Earnings

0.800
0.0000.00%

15min DelayMarket Closed Jan 14 16:00 ET

55.11MMarket Cap-80.00P/E (TTM)

Eastwood Bio-Medical Canada Inc (EBM) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jul 31, 2025

(Q2)Apr 30, 2025

(Q1)Jan 31, 2025

(FY)Oct 31, 2024

(Q4)Oct 31, 2024

(Q3)Jul 31, 2024

(Q2)Apr 30, 2024

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

Total revenue

-33.36%125.46K

-43.21%76.78K

6.82%214.72K

-19.11%702.08K

37.60%177.61K

0.67%188.26K

-38.45%135.2K

-39.49%201K

-33.22%867.94K

-66.11%129.08K

Operating revenue

-33.36%125.46K

-43.21%76.78K

6.82%214.72K

-19.11%702.08K

37.60%177.61K

0.67%188.26K

-38.45%135.2K

-39.49%201K

-33.22%867.94K

-66.11%129.08K

Cost of revenue

-32.40%38.76K

-19.23%39.38K

-8.44%55.66K

-22.49%247.69K

1.50%80.81K

-6.69%57.34K

-47.49%48.75K

-29.04%60.79K

-19.51%319.57K

-52.40%79.62K

Gross profit

-33.78%86.69K

-56.73%37.41K

13.45%159.06K

-17.14%454.39K

95.71%96.81K

4.27%130.92K

-31.83%86.45K

-43.12%140.21K

-39.26%548.37K

-76.85%49.47K

Operating expense

-36.82%146.7K

-12.42%192.99K

-2.48%199.25K

-15.33%892.09K

17.17%235.24K

-3.53%232.19K

-26.35%220.35K

-34.71%204.31K

2.08%1.05M

-15.48%200.76K

Selling and administrative expenses

-30.97%102.66K

15.73%134.55K

-20.50%111.15K

-21.34%527.08K

-0.00%122.31K

-7.37%148.71K

-33.97%116.26K

-33.78%139.8K

1.60%670.04K

-15.42%122.32K

-Selling and marketing expense

383.96%8.84K

--1.56K

-77.35%188

-9.19%3.01K

-82.74%348

630.80%1.83K

--0

32.17%830

22.37%3.31K

51.01%2.02K

-General and administrative expense

-36.13%93.82K

14.39%132.98K

-20.16%110.96K

-21.40%524.07K

1.38%121.96K

-8.37%146.89K

-33.81%116.26K

-33.98%138.97K

1.51%666.73K

-16.04%120.3K

Depreciation amortization depletion

--0

68.81%44.96K

-0.29%107.54K

2.50%27.64K

-1.22%26.64K

0.94%107.85K

0.94%26.96K

-Depreciation and amortization

--0

68.81%44.96K

-0.29%107.54K

2.50%27.64K

-1.22%26.64K

0.94%107.85K

0.94%26.96K

Other operating expenses

-22.53%44.03K

-24.55%58.45K

13.91%43.14K

-6.60%257.47K

65.67%85.29K

6.92%56.84K

-19.45%77.46K

-49.41%37.88K

3.74%275.68K

-22.23%51.48K

Operating profit

40.75%-60K

-16.19%-155.59K

37.30%-40.19K

13.36%-437.7K

8.50%-138.43K

12.03%-101.26K

22.31%-133.91K

3.51%-64.1K

-290.58%-505.2K

-534.00%-151.3K

Net non-operating interest income (expenses)

166.33%2.14K

51.73%-1.1K

-202.30%-801

77.68%-6.29K

93.92%-1.23K

-50.35%-3.23K

31.81%-2.29K

132.20%783

-163.09%-28.16K

-178.58%-20.23K

Non-operating interest income

----

--0

----

Non-operating interest expense

----

-77.68%6.29K

----

163.09%28.16K

----

Total other finance cost

-166.33%-2.14K

-51.73%1.1K

202.30%801

----

50.35%3.23K

-31.81%2.29K

-132.12%-783

----

Other net income (expenses)

100.48%51

-103.48%-210

-102.18%-198

10.19%-11.88K

-28.12%-16.28K

-24,243.18%-10.71K

5,483.93%6.03K

2,560.43%9.08K

-34.62%-13.23K

-306.23%-12.71K

Gain on sale of security

100.48%51

-103.90%-210

-102.04%-198

41.87%-7.21K

3.80%-11.6K

-24,243.18%-10.71K

4,906.25%5.38K

5,533.52%9.73K

-120.87%-12.4K

-216.21%-12.06K

Special income (charges)

----

--0

-459.02%-4.68K

-623.18%-4.68K

--0

--647

-240.53%-647

82.57%-837

86.53%-647

-Less:Write off

----

--0

459.02%4.68K

623.18%4.68K

--0

---647

240.53%647

-82.57%837

-86.53%647

Income before tax

49.82%-57.81K

-20.54%-156.9K

24.06%-41.19K

16.60%-455.87K

15.36%-155.94K

1.79%-115.21K

25.97%-130.16K

21.66%-54.24K

-264.69%-546.6K

-638.02%-184.23K

Income tax

Earnings from equity interest net of tax

Net income

49.82%-57.81K

-20.54%-156.9K

24.06%-41.19K

16.60%-455.87K

15.36%-155.94K

1.79%-115.21K

25.97%-130.16K

21.66%-54.24K

-264.69%-546.6K

-638.02%-184.23K

Net income continuous operations

49.82%-57.81K

-20.54%-156.9K

24.06%-41.19K

16.60%-455.87K

15.36%-155.94K

1.79%-115.21K

25.97%-130.16K

21.66%-54.24K

-264.69%-546.6K

-638.02%-184.23K

Noncontrolling interests

Net income attributable to the company

49.82%-57.81K

-20.54%-156.9K

24.06%-41.19K

16.60%-455.87K

15.36%-155.94K

1.79%-115.21K

25.97%-130.16K

21.66%-54.24K

-264.69%-546.6K

-638.02%-184.23K

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

49.82%-57.81K

-20.54%-156.9K

24.06%-41.19K

16.60%-455.87K

15.36%-155.94K

1.79%-115.21K

25.97%-130.16K

21.66%-54.24K

-264.69%-546.6K

-638.02%-184.23K

Diluted earnings per share

0.00%-0.01

-359.56%-0.01

Basic earnings per share

0.00%-0.01

-359.56%-0.01

Dividend per share

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jul 31, 2025	(Q2)Apr 30, 2025	(Q1)Jan 31, 2025	(FY)Oct 31, 2024	(Q4)Oct 31, 2024	(Q3)Jul 31, 2024	(Q2)Apr 30, 2024	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023
Total revenue	-33.36%125.46K	-43.21%76.78K	6.82%214.72K	-19.11%702.08K	37.60%177.61K	0.67%188.26K	-38.45%135.2K	-39.49%201K	-33.22%867.94K	-66.11%129.08K
Operating revenue	-33.36%125.46K	-43.21%76.78K	6.82%214.72K	-19.11%702.08K	37.60%177.61K	0.67%188.26K	-38.45%135.2K	-39.49%201K	-33.22%867.94K	-66.11%129.08K
Cost of revenue	-32.40%38.76K	-19.23%39.38K	-8.44%55.66K	-22.49%247.69K	1.50%80.81K	-6.69%57.34K	-47.49%48.75K	-29.04%60.79K	-19.51%319.57K	-52.40%79.62K
Gross profit	-33.78%86.69K	-56.73%37.41K	13.45%159.06K	-17.14%454.39K	95.71%96.81K	4.27%130.92K	-31.83%86.45K	-43.12%140.21K	-39.26%548.37K	-76.85%49.47K
Operating expense	-36.82%146.7K	-12.42%192.99K	-2.48%199.25K	-15.33%892.09K	17.17%235.24K	-3.53%232.19K	-26.35%220.35K	-34.71%204.31K	2.08%1.05M	-15.48%200.76K
Selling and administrative expenses	-30.97%102.66K	15.73%134.55K	-20.50%111.15K	-21.34%527.08K	-0.00%122.31K	-7.37%148.71K	-33.97%116.26K	-33.78%139.8K	1.60%670.04K	-15.42%122.32K
-Selling and marketing expense	383.96%8.84K	--1.56K	-77.35%188	-9.19%3.01K	-82.74%348	630.80%1.83K	--0	32.17%830	22.37%3.31K	51.01%2.02K
-General and administrative expense	-36.13%93.82K	14.39%132.98K	-20.16%110.96K	-21.40%524.07K	1.38%121.96K	-8.37%146.89K	-33.81%116.26K	-33.98%138.97K	1.51%666.73K	-16.04%120.3K
Depreciation amortization depletion	--0	--0	68.81%44.96K	-0.29%107.54K	2.50%27.64K	-1.22%26.64K	-1.22%26.64K	-1.22%26.64K	0.94%107.85K	0.94%26.96K
-Depreciation and amortization	--0	--0	68.81%44.96K	-0.29%107.54K	2.50%27.64K	-1.22%26.64K	-1.22%26.64K	-1.22%26.64K	0.94%107.85K	0.94%26.96K
Other operating expenses	-22.53%44.03K	-24.55%58.45K	13.91%43.14K	-6.60%257.47K	65.67%85.29K	6.92%56.84K	-19.45%77.46K	-49.41%37.88K	3.74%275.68K	-22.23%51.48K
Operating profit	40.75%-60K	-16.19%-155.59K	37.30%-40.19K	13.36%-437.7K	8.50%-138.43K	12.03%-101.26K	22.31%-133.91K	3.51%-64.1K	-290.58%-505.2K	-534.00%-151.3K
Net non-operating interest income (expenses)	166.33%2.14K	51.73%-1.1K	-202.30%-801	77.68%-6.29K	93.92%-1.23K	-50.35%-3.23K	31.81%-2.29K	132.20%783	-163.09%-28.16K	-178.58%-20.23K
Non-operating interest income	----	----	----	----	----	--0	----	----	----	----
Non-operating interest expense	----	----	----	-77.68%6.29K	----	----	----	----	163.09%28.16K	----
Total other finance cost	-166.33%-2.14K	-51.73%1.1K	202.30%801	----	----	50.35%3.23K	-31.81%2.29K	-132.12%-783	----	----
Other net income (expenses)	100.48%51	-103.48%-210	-102.18%-198	10.19%-11.88K	-28.12%-16.28K	-24,243.18%-10.71K	5,483.93%6.03K	2,560.43%9.08K	-34.62%-13.23K	-306.23%-12.71K
Gain on sale of security	100.48%51	-103.90%-210	-102.04%-198	41.87%-7.21K	3.80%-11.6K	-24,243.18%-10.71K	4,906.25%5.38K	5,533.52%9.73K	-120.87%-12.4K	-216.21%-12.06K
Special income (charges)	----	--0	--0	-459.02%-4.68K	-623.18%-4.68K	--0	--647	-240.53%-647	82.57%-837	86.53%-647
-Less:Write off	----	--0	--0	459.02%4.68K	623.18%4.68K	--0	---647	240.53%647	-82.57%837	-86.53%647
Income before tax	49.82%-57.81K	-20.54%-156.9K	24.06%-41.19K	16.60%-455.87K	15.36%-155.94K	1.79%-115.21K	25.97%-130.16K	21.66%-54.24K	-264.69%-546.6K	-638.02%-184.23K
Income tax
Earnings from equity interest net of tax
Net income	49.82%-57.81K	-20.54%-156.9K	24.06%-41.19K	16.60%-455.87K	15.36%-155.94K	1.79%-115.21K	25.97%-130.16K	21.66%-54.24K	-264.69%-546.6K	-638.02%-184.23K
Net income continuous operations	49.82%-57.81K	-20.54%-156.9K	24.06%-41.19K	16.60%-455.87K	15.36%-155.94K	1.79%-115.21K	25.97%-130.16K	21.66%-54.24K	-264.69%-546.6K	-638.02%-184.23K
Noncontrolling interests
Net income attributable to the company	49.82%-57.81K	-20.54%-156.9K	24.06%-41.19K	16.60%-455.87K	15.36%-155.94K	1.79%-115.21K	25.97%-130.16K	21.66%-54.24K	-264.69%-546.6K	-638.02%-184.23K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	49.82%-57.81K	-20.54%-156.9K	24.06%-41.19K	16.60%-455.87K	15.36%-155.94K	1.79%-115.21K	25.97%-130.16K	21.66%-54.24K	-264.69%-546.6K	-638.02%-184.23K
Diluted earnings per share	0.00%-0.01	0.00%-0.01	0.00%-0.01	0.00%-0.01	0	0.00%-0.01	0.00%-0.01	0.00%-0.01	-359.56%-0.01	0
Basic earnings per share	0.00%-0.01	0.00%-0.01	0.00%-0.01	0.00%-0.01	0	0.00%-0.01	0.00%-0.01	0.00%-0.01	-359.56%-0.01	0
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"